AbCellera Biologics Inc (ABCL)
NASDAQ
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 23.653 | 13.206 | 11.087 | -9.666 |
Return on Equity (%) | 28.637 | 16.535 | 14.034 | -12.273 |
Return on Invested Capital (%) | 41.282 | 21.901 | 18.908 | -19.036 |
Operating Margin (%) | 70.487 | 59.801 | 50.089 | -457.67 |
Net Profit Margin (%) | 51.004 | 40.902 | 32.656 | -385.005 |
Book Value Per Share | 2.538 | 2.917 | 3.624 | 3.337 |
Earnings Per Share | 0.441 | 0.54 | 0.545 | -0.496 |
Cash Per Share | 2.205 | 1.675 | 1.329 | 0.452 |
Working Capital Per Share | 2.634 | 2.846 | 3.12 | 2.553 |
Operating Profit Per Share | 0.865 | 1.32 | 1.669 | 0.129 |
EBIT Per Share | 0.586 | 0.771 | 0.822 | -0.59 |
EBITDA Per Share | 0.586 | 0.771 | 0.822 | -0.59 |
Free Cash Flow Per Share | 0.476 | 0.685 | 0.681 | -0.338 |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Shares Outstanding | 269.5M | 283.26M | 286.85M | 290.82M |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Shares Outstanding | 286.85M | 288.43M | 289.19M | 289.78M | 290.82M | 293.62M | 294.67M | 295.16M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -394.915 | N/A | N/A | N/A | -429.445 | N/A | N/A |
Net Profit Margin (%) | N/A | -328.986 | N/A | N/A | N/A | -407.977 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 869.26M |
Price to Earnings Ratio | -6.1 |
Price to Sales Ratio | 23.49 |
Price to Cash Ratio | 6.7 |
Price to Book Ratio | 0.77 |
Dividend Yield | - |
Shares Outstanding | 294.67M |
Average Volume (1 week) | 2.02M |
Average Volume (1 Month) | 2.49M |
52 Week Change | -46.67% |
52 Week High | 6.055 |
52 Week Low | 2.335 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.